ResultsIQ › Latest results › Chemcon Speciality Chemicals Limited

Chemcon Speciality Chemicals Limited Q4 FY25 results deck summary

NSE: CHEMCON · BSE: 543233

Results deck of 19 May 2025, summarised by AI from the filing.

P-10 and P-11 units at Manjusar targeted for commissioning in H1 FY26

Key takeaways

Guidance P-10 and P-11 units at Manjusar targeted for commissioning in H1 FY26
Change Q4 FY25 revenue ₹54.9 cr vs ₹59.6 cr in Q4 FY24, while PAT rose to ₹3.9 cr from ₹2.9 cr
Driver New products aligned with import substitution are undergoing client approvals with trial dispatches commenced
Risk Subdued demand across organic and inorganic segments due to global economic uncertainty and lower realizations

Chemcon Speciality Chemicals Limited Q1 FY27 results

As filed: Revenue ₹66.5 cr (+23% year on year), EBITDA ₹15.4 cr (+120% year on year), PAT ₹11.0 cr (+83% year on year), EBITDA margin 23.2% (+1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

Q4 FY26: Revenue ₹75.4 cr (+37% year on year), EBITDA ₹8.9 cr (+48% year on year), PAT ₹6.4 cr (+59% year on year), EBITDA margin 11.8% (+86 bps). Score 84 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was above it. EBITDA margin rose 86 bps year on year. Other income 47% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Profit rose ₹2.4 cr on a year ago, more than the ₹1.0 cr it added the year before. Share price after the results: +8.8% in 29 days (Nifty 500: +2.4%).
Q3 FY26: Revenue ₹57.3 cr (+6% year on year), EBITDA ₹6.7 cr (−45% year on year), PAT ₹5.1 cr (−43% year on year), EBITDA margin 11.6% (−1,000 bps). Score 29 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 1000 bps year on year. Other income 53% of PBT. Profit fell 15% from last quarter. Share price after the results: −18.5% in 29 days (Nifty 500: −9.6%).
Q2 FY26: Revenue ₹54.0 cr (+2% year on year), EBITDA ₹7.0 cr (−22% year on year), PAT ₹6.0 cr (0% year on year), EBITDA margin 13.0% (−402 bps). Score 37 of 100, Below trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 402 bps year on year. Other income 50% of PBT. Share price after the results: −15.1% in 28 days (Nifty 500: −0.5%).
Q1 FY26: Revenue ₹54.0 cr (+17% year on year), EBITDA ₹7.0 cr (0% year on year), PAT ₹6.0 cr (+20% year on year), EBITDA margin 13.0% (−225 bps). Score 50 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 225 bps year on year. Other income 50% of PBT. Share price after the results: −11.7% in 30 days (Nifty 500: +0.1%).
Q4 FY25: Revenue ₹55.0 cr (−8% year on year), EBITDA ₹6.0 cr (+20% year on year), PAT ₹4.0 cr (+33% year on year), EBITDA margin 10.9% (+258 bps). Score 43 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 258 bps year on year. Other income 60% of PBT. Profit fell 56% from last quarter. Share price after the results: −9.8% in 30 days (Nifty 500: +1.8%).
Q3 FY25: Revenue ₹54.0 cr (+2% year on year), EBITDA ₹12.0 cr (+71% year on year), PAT ₹9.0 cr (+125% year on year), EBITDA margin 22.2% (+901 bps). Score 71 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 901 bps year on year. Other income 33% of PBT.
Q2 FY25: Revenue ₹53.0 cr (−29% year on year), EBITDA ₹9.0 cr (0% year on year), PAT ₹6.0 cr (0% year on year), EBITDA margin 17.0% (+498 bps). Score 22 of 100, Below trend. EBITDA margin rose 498 bps year on year. Other income 44% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Chemcon Speciality Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.